Visolis

Using synthetic biology to manufacture carbon-negative materials

First Investment: 2017

With support from AI-powered high-throughput screening and data modeling, Visolis engineers microbial strains that efficiently produce desired molecules. Traditional chemical catalysis turns these products into carbon-negative, bio-based specialty materials for multiple end markets and industries, from cosmetics to cars.

Explore Companies

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs

Nilo Therapeutics

Mapping the brain-body axis to achieve proper immune balance

Avicenna Biosciences

Using AI to speed through the last mile of drug discovery